Moleculin Biotech Inc.

MBRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.52

-$0.25 (-32.74%)

At close: Sep 21, 2026, 4:00 PM ET

$0.54

+$0.02 (+3.98%)

Pre-market: Sep 22, 2026, 9:21 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.78M

Enterprise Value $-4.34M

Beta 1.92

Average Volume 954.54K

Shares Outstanding (Diluted) 5.68M

Shares Change YoY 814.69%

Institutional Ownership 3.69%

Exchange NASDAQ

ISIN US60855D4088

Price Performance

Price Change 1M -14.8%

Price Change 3M -81.1%

Price Change 6M -79.1%

Price Change YTD -85.6%

Price Change 1Y -94.9%

Price Change 3Y -99.6%

Price Change 5Y -100.0%

1M CAGR (ann.) 27.0%

1Y CAGR (ann.) -95.0%

5Y CAGR (ann.) -78.5%

All-Time CAGR -63.7%

Valuation

PE Ratio -0.03

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.00

PS Ratio N/A

Forward PS 0.10

PB Ratio 0.24

P/FCF Ratio -0.11

P/Adj. FCF Ratio -0.10

P/OCF Ratio -0.12

EV/Sales N/A

EV/EBIT 0.19

EV/EBITDA 0.14

EV/FCF 0.17

Earnings Yield -3294.2%

FCF Yield -913.5%

Adj. FCF Yield -959.4%

Financial Health

Net Cash $7.12M

Total Debt $147K

Cash & Short-Term Investments $7.26M

Total Assets $21.09M

Current Ratio 0.94

Quick Ratio 0.94

Debt / Equity Ratio 0.03

Debt / EBITDA -0.00

Debt / FCF -0.01

OCF / Debt -172.50

Interest Coverage -370.18

Altman Z-Score -18.45

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -5.0%

Returns

Return on Assets -143.8%

Return on Equity -816.6%

Return on Invested Capital -242.3%

Return on Capital Employed -245.2%

Return on Tangible Assets -305.1%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 95.1%

EPS CAGR 5Y 35.4%

EPS CAGR 10Y 14.7%

FCF CAGR 3Y 0.8%

FCF CAGR 5Y -1.3%

FCF CAGR 10Y -10.8%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y 34.0%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.44

EPS Growth Est (next Q) -97.4%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $3

Price Target Upside 476.9%

Cash Flow

Operating Cash Flow $-25.36M

Free Cash Flow $-25.36M

Adj. Free Cash Flow $-26.63M

FCF Per Share -$4.46

OCF Per Share -$4.46

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-8K

Operating Income $-28.87M

EBITDA $-30.21M

Net Income $-30.33M

EPS (Diluted) -$17.13

Revenue / Employee N/A

Profit / Employee $-1.78M

Employees 17